
A Million-Dollar Genetic Test: The PALB2 Mutation, Cancer Risks, and What to Do When Your DNA Surprises You
Taking an advanced DNA test and seeing 'pathogenic PALB2 variant' on the report is deeply unsettling: lifetime breast cancer risk jumps up to 53%. Panic is a natural first reaction, yet evidence-based genetics teaches calm precision: a mutation is not a disease, but an early-warning map for proactive care.
Drawing on the real experience of food chemist Olga Kosnikova and clinical geneticists, we break down why consumer microarrays miss inherited glitches, how the PALB2 protein repairs double-strand DNA breaks alongside BRCA1/BRCA2, and why alternating contrast MRI and mammography every six months catches interval tumors far more reliably than fear.
Whole exome sequencing also reveals pharmacogenetics—from slower liver clearance of omeprazole to screening for malignant hyperthermia under anesthesia.



